Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Illumina, Abbott, Roche, Rheonix, Firefly, Others Win US Patents

Premium

Lawrence Livermore National Security and The University of California have been awarded US Patent No. 8,610,032, "Laser heating of aqueous samples on a micro-optical-electro-mechanical system."

Neil Beer and Ian Kennedy are named as inventors.


Ibis Biosciences (Abbott Laboratories) has been awarded US Patent No. 8,609,430, "Sample processing units, systems, and related methods."

Steven Hofstadler, Jared Drader, Jose Gutierrez, Paul Gleason, Rex Bare, Robert Miller, and Jeffrey Smith are named as inventors.


Illumina has been awarded US Patent No. 8,609,341, "Uniform fragmentation of DNA using binding proteins."

Frank Steemers and Jonathan Boutell are named as inventors.


Roche has been awarded US Patent No. 8,609,340, "Control nucleic acids for multiple parameters."

Meike Eickhoff, Ellen Fiss, Joachim Glaubitz, Niclas Hitziger, Stephen Will, and Dirk Zimmermann are named as inventors.


454 Life Sciences (Roche) has been awarded US Patent No. 8,609,339, "System and method for emulsion breaking and recovery of biological elements."

Yue Suo is named as the inventor.


Firefly BioWorks has been awarded US Patent No. 8,609,337, "Nucleic acid detection and quantification by post-hybridization labeling and universal encoding."

Daniel Pregibon, Isaac Stoner, Andreas Windemuth, and Timothy Erps are named as inventors.


Rheonix has been awarded US Patent No. 8,609,039, "Microfluidic systems and control methods."

Peng Zhou and Lincoln Young are named as inventors.


The University of British Columbia has been awarded US Patent No. 8,608,929, "Apparatus and methods for concentrating and separating particles such as molecules."

Andrea Marziali and David Broemeling are named as inventors.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.